Web-based Genetic Research on Lupus

The goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this understanding to drug development efforts with the investigator's partners at Pfizer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Systemic Lupus Erythematosus Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Lupus Erythematosus, Systemic Skin and Connective Tissue Diseases

Age range

6 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Www.23Andme.Com/Lupus

Mountain View, California, 94041, United States

About this study

Lupus is a difficult disease to diagnose and one that's difficult to manage, given the lack of specific medicines to treat lupus and the side-effects of current medications. The investigators believe genetics may play a critical role in developing better lupus diagnoses and treatments. If individuals are eligible to participate, the investigators will send a 23andMe DNA saliva kit at no cost. Participants will be asked to take a 15 minute online survey with questions about their lupus experience, symptoms and response to treatments, in addition to five additional bi-monthly short surveys and one final study survey during the 12-month participation. Learn more and join the lupus study today: https://www.23andme.com/lupus/

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

diagnosed with lupus by a qualified physician.
consents to have 23andMe (via a partner) contact the physician to obtain medical record information
willing to submit a saliva sample for DNA testing and complete online surveys related to condition
at least 6 years old (minors under 18 require parental consent to enroll)
access to the internet
resides in the United States

Exclusion criteria

Treatment and study plan

Primary outcomes

Salivary DNA sample for genetic analysis

Time frame: 12 months
Online survey

Time frame: 12 months

Questions about lupus experience, symptoms and response to treatment

Sponsors and collaborators

Lead sponsor

23andMe, Inc.

Industry

Collaborators

Pfizer

Registry information

Important dates

Study start: 2015
Primary completion: 2017
Study completion: 2017
First posted: Aug 21, 2015
Registry last updated: Jan 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed